Green, Claire <br/><br/>
Most acute myeloid leukaemia patients with intermediate mutant FLT3/ITD levels do not have detectable bi-allelic disease, indicating that heterozygous disease alone is associated with an adverse outcome.  [electronic resource] 

 -  British journal of haematology  Jul 2008 
 - 423-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2008.07196.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Case-Control Studies<br/>Gene Duplication<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--genetics<br/>Prognosis<br/>Recurrence<br/>Tandem Repeat Sequences<br/>fms-Like Tyrosine Kinase 3--genetics